Brazil's new rules on antibiotic prescriptions are good news for multinationals
This article was originally published in SRA
Executive Summary
A new resolution that has just come into force in Brazil means that patients will only be able to buy drugs containing antimicrobials with a controlled prescription1. Although the measure came largely in response to concerns over increasing resistance to antibiotics, it is also a positive move for multinationals because it means that if a doctor prescribes a brand, the pharmacist is more likely to actually dispense it.